Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

16.48 -0.05 (-0.27%)
Streaming Delayed Price Updated: 3:43 PM EDT, Aug 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hims & Hers Health Inc

< Previous 1 2 3 4 5 Next >
Top 3 Stocks to Watch: Options Traders Bet on Big Gains
Three stocks have stood out for call option traders to bet on in the coming months as a view for a recovery rally after an S&P 500 sell-off last week 
Via MarketBeat
Topics Stocks
Exposures US Equities
MarketBeat Week in Review – 8/5 - 8/9
Stocks were looking for direction to end the week, but next week may bring more volatility with the latest reading on inflation and the start of retail earnings 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
Hims & Hers stock is showing the market why its fair value is double-digits above where it trades today, with Wall Street analysts to agree 
Via MarketBeat
Topics Bonds ETFs
Exposures Debt Markets
Hims & Hers Health Inc. (NYSE: HIMS) Near the Top of Equities by Percentage Gain on 2/27
Via Investor Brand Network
Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results
From Hims & Hers
Via Business Wire
Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Hims & Hers stock is looking like a worthy dip to watch in the coming months, especially as its decline had nothing to do with company operations 
Via MarketBeat
Can the New CEO Revive This Struggling Telehealth Stock?
Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023 
Via MarketBeat
Topics Earnings
Exposures Financial
Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
From Hims & Hers
Via Business Wire
Is This Telehealth Stock a Buy After the Recent Pullback?
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions. 
Via MarketBeat
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
From Hims & Hers
Via Business Wire
Eli Lilly's Stock Surge Driven by GLP-1 Demand
Shares of Eli Lilly stock are about to hit a new all-time high, sponsored by the pending approval of new weight loss drugs 
Via MarketBeat
Topics Economy
Exposures Interest Rates
3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & Hers
These three stocks are looking to get a chunk of the total added jobs in the economy, meaning that analyst double-digit upside and growth projections are real 
Via MarketBeat
Topics Economy
Exposures Economy
MarketBeat Week in Review – 6/3 - 6/7
Equity markets shrugged off a much hotter-than-expected jobs report, but there could be more volatility after the next readings on inflation come out next week 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Hims & Hers Health Soars on Generic GLP-1 Rollout Plans
Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments 
Via MarketBeat
Call Option Volumes Spiked For These 3 Stocks
Option traders decided to plow into call contracts for these three stocks, investors can see the specific fundamental reasons behind this decision 
Via MarketBeat
LifeMD Can Surge on Its GLP-1 Offerings
LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result 
Via MarketBeat
Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
From Hims & Hers
Via Business Wire
Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
From Hims & Hers
Via Business Wire
3 Stocks That Suddenly Drew in Options Traders
Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside. 
Via MarketBeat
Hims & Hers Health Stock Could Become a Wealth Compounder
Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24 
Via MarketBeat
Topics Economy
Exposures Economy
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
From Hims & Hers Health, Inc.
Via Business Wire
3 Stocks With Unusual Call Option Activity
Three stocks reported rising call option buying activity could see even higher prices soon. Analysts see the writing on the wall, and traders stampeded in 
Via MarketBeat
Topics Economy
Exposures Interest Rates
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
Can WeightWatchers Regain its Mojo after Oprah Steps Down?
WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). 
Via MarketBeat
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Stock Rises On Stimulating Earnings Growth
Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audience 
Via MarketBeat
bluebird bio stock is ripe for a 400% institutional short squeeze
Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From Hims & Hers Health, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.